Publication | Average age of onset | Length of follow-up | Age of onset threshold | No patients with/without an event | Event ratio (95% CI) | Inference |
---|---|---|---|---|---|---|
Taghred [19] | – | 12 months | < 1 year > 1 year | Age of onset < 1 year: 70/40 > 1 year:23/53 | OR: 4.0 p < 0.001 | Age of onset lesser than 1 year is associated with an increased risk of drug resistance |
Jeong [20] | Median (IQR): 5 (3–7.2) months | – | < 1 year > 1 year | 650/896 | OR 1.9 (1.4–2.5) p < 0.001 | Age of onset of less than 1 year increases the risk of drug resistance |
Rawat [22] | Median(IQR): 15 (0–56) months | 12 months | 5 years | 581/475 | OR 2.02 (1.31–3.13) p = 0.0016 | Age of Onset younger than 5 years is associated with increased risk for drug resistance or recurrence |
Chen [18] | Mean (SD) 22.18 (± 1.38)years | 4–9 years | – | 41/100 | 2.508 (0.270, 23.316) p = 0.419 | Age of onset is not associated with drug resistance |
Berg [23] | – | ≥ 10 years < 10 years | 2–5 years | 205/311 | – | – |
Berg [24] | The group followed < 10 years: 7.0 (4.2) Group followed ≥ 10 years: 5.5 (4.1) | ≥ 10 years < 10 years | – | 347/266 | Age of onset < 2 Hazard ratio: 1.000 Age of onset 2–5 Hazard ratio: 0.72 (0.48, 1.11) Age of onset 5–10 Hazard ratio: 0.78 (0.52, 1.18) Age of onset 10 + Hazard Ratio: 0.50 (0.30, 0.82) | Age of onset of less than 2 years increases the likelihood of drug resistance |
Karaoglu [25] | Mean Drug-resistant: 1.85 years Drug receptive: 4.92 years | Median 46 months (range: 28–126 months) | – | 177/281 | p < 0.001 Univariate analysis | There is an association between the Early age of Onset and the development of drug-resistant epilepsy |
Senem [28] | Range, intractable group: 0–1 Control group: 1–5 | 4 years | > 1 year < 1 year | 61/180 | Odd ratio Age < 1: 9.43 (3.66–24.30) 1–4 years: 1.79 (0.65–4.89) 5 and above: 1.04 (0.11–9.91) p = 0.001 | Age of onset of less than one year was found to be associated with an increased risk for intractable seizure |
Lattanzi [26] | Mean (± SD) Overall = 56.7 (± 14.9)years Refractory group = 52.1 (± 15.3)years Responsive group = 57.8 (± 14.7)years | Median (range) 5 (3–9) years | – | 29/130 | Multivariate OR = 0.97 p = 0.044 | There is an association between younger age of stroke onset and the development of drug resistance post-stroke epilepsy |
Ramos-Lizana [27] | 4.8 years (± 3.8 SD) Mean used | Mean (± SD) (range) 76.2 (± 35.2 SD) month (24–139) | > 1 year | 30/313 | Univariate HR = 4.9 p = 0.000 Multivariate HR = 2.6 p = 0.051 | Age of onset lesser than 1 year was found to be associated with refractory epilepsy with univariate analysis and almost associated with multivariate analysis |
Tripathi [29] | Mean(± SD): Case = 5.18 (± 7.62) Control = 5.62 (± 9.18) | – | < 14 years > 14 years | 200/200 | Multivariate analysis Age of onset < 14 OR = 3.09 + p < 0.005 | There is an association between an age of onset of less than 14 years and the development of intractable epilepsy |
Sara [21] | Mean ± SD 31 ± 21 | Mean 9.4 years SD (4.2) Median 8.1 years range (5.0–23.1) | 17 year | 143/43 | – | Age of onset does not predict drug resistance |